SARS-CoV-2 neutralising antibody response to bivalent booster after omicron infection

Lancet Microbe. 2024 Jan;5(1):e8. doi: 10.1016/S2666-5247(23)00293-8. Epub 2023 Oct 30.

Authors

David N Springer¹, Iris Medits¹, Lukas Weseslindtner¹, Karin Stiasny¹, Judith H Aberle²

Affiliations

¹ Center for Virology, Medical University of Vienna, Vienna 1090, Austria.
² Center for Virology, Medical University of Vienna, Vienna 1090, Austria. Electronic address: judith.aberle@meduniwien.ac.at.

PMID: 37918419
DOI: 10.1016/S2666-5247(23)00293-8

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Neutralizing / therapeutic use
COVID-19*
Humans
SARS-CoV-2

Substances

Antibodies, Neutralizing